Gyogyszerkutato Intezet Kft.

Egyt Gyogyszervegyeszeti Gyar

Egis Gyogyszergyar

Gyogyszerkutato Intezet

Cyogyszerkutato Intezet Kft

Gyogyszerkutato Intezet Kv.

Katalin Goldschmidt

Ferenc Andrasi

Imre Moravcsik

Tamas Hamori

Jeno Korosi

Pal Berzsenyi

Peter Botka

Sandor Farkas

Istvan Tarnawa

Lajos Toldy

Laszlo Sebestyen

Zsuzsanna Fittler

Istvan Sziraki

Eszter Hodula

Klara Sutka

Valeria Vitkoczi

Antal Simay

Tibor Lang

Peter Matyus

Lajos Farkas

Agnes Papp

Erzsebet Zara

Eva Gal

Ildiko Mathe

Marta Rusz

Istvan Elekes

Tibor Balogh

Zoltan Zubovics

Gabor Zolyomi

Jozsef Szekely

Zsuzsanna Lang Nee Rihmer

Lajos Ila

Eleonora Sineger

Ferene Andrasi

P Eter Botka

P Al Berzsenyi

Ferenc Andr Asi

Tam As H Amori

Istv An Tarnawa

Jen O K Or Osi

Katalin Szilagyi

Katalin Gorgenyi

Jozsef Gyimesi

S Andor Farkas

An N-benzoylamino acid compound of the formula (I), ##STR1## wherein R.sup.3 is an NR.sup.4 R.sup.5 group where R.sup.4 and R.sup.5 which are the same or different are selected from the group consisting of hydrogen, a hydroxyl group, a C.sub.1-12 alkyl group, a C.sub.1-4 alkyl group substituted by a hydroxyl group and a C.sub.1-4 alkyl group substituted by an amino group;

N-benzoylamino acid derivatives, pharmaceutical compositions containing

The invention relates to novel N-benzoylamino acid derivatives of the general formula (I), ##STR1## wherein R.sup.1 and R.sup.2, which are the same or different, stand for a hydroxyl group optionally bearing an acetyl group; or a C.sub.1-6 alkoxy group optionally substituted by a phenyl group;

N-benzoyl amino acid derivatives pharmaceutical compositions containing

The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)

N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic

The invention relates to novel N-acyl-2,3-benzodiazepine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in this specification, a more complete description of the compounds may be found. The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.

N acyl 2 3 benzodiazepine derivatives pharmaceutical compositions

N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions

The invention relates to novel N-acyl-2,3-benzodiezapine derivatives and a method of treating spasms of the skeletal musculature therewith.

N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of

N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions

The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in the specification, a more complete description of the compounds may be found. The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.

N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions

This invention relates to novel compounds of the general formula (I) and the pharmaceutically acceptable acid addition salts thereof. In the general formula (I) ##STR1## wherein Lip, A.sup.1, A.sup.2, Het and n are defined as in the specification. The compounds of the general formula (I) inhibit the lipid peroxidation and therefore, they are useful for the treatment or prevention of diseases and conditions wherein the inhibition of lipid peroxidation is desirable.

Piperazine and homopiperazine derivatives, pharmaceutical compositions

The invention relates to new 5H-2,3-benzodiazepine derivatives and a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same. The new 5H-2,3-benzodiazepine derivatives of the invention possess valuable central nervous effect and in particular exert antiaggressive, anxiolytic, narcosis potentiating and soporific properties.

5H-2,3-benzodiazepine derivatives and pharmaceutical compositions

The invention relates to new 3,4-dihydro-5H-2,3-benzodiazepine derivatives of general formula (I) and pharmaceutically acceptable acid addition salts thereof, ##STR1## wherein R represents a phenyl group optionally carrying one or two substituents selected from the group consisting of halogen, hydroxy, C.sub.1-4 alkoxy and benzyloxy; a furyl or a thienyl group,

3,4-Dihydro-5H-2,3-benzodiazepine derivatives and pharmaceutical use

Growing community of inventors

Budapest, Hungary

Katalin Goldschmidt